Drug Shortage Report for PULMICORT NEBUAMP 0.125 MG/ML

Last updated on 2023-04-06 History
Report ID 184729
Drug Identification Number 02229099
Brand name PULMICORT NEBUAMP 0.125 MG/ML
Common or Proper name budesonide
Company Name ASTRAZENECA CANADA INC
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 0.125MG
Dosage form(s) SUSPENSION
Route of administration INHALATION INHALATION
Packaging size 20 ampoules
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-02-15
Estimated end date 2023-04-05
Actual end date 2023-04-05
Shortage status Resolved
Updated date 2023-04-06
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-02-16 English Compare
v2 2023-02-16 French Compare
v3 2023-03-29 English Compare
v4 2023-03-29 French Compare
v5 2023-04-06 English Compare
v6 2023-04-06 French Compare

Showing 1 to 6 of 6